Top
Summary
All studies
Cases
RCTs
Peer-reviewed
All outcomes

Feedback
 
Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
c19early.org COVID-19 treatment researchpHOXWELLpHOXWELL (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

Outcomes in COVID-19 pHOXWELL studies

0 0.5 1 1.5+ All studies 47% 1 556 Improvement, Studies, Patients Relative Risk Cases 47% 1 556 RCTs 47% 1 556 Prophylaxis 47% 1 556 PHOXWELL for COVID-19 c19early.org December 2024 FavorspHOXWELL Favorscontrol
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Balmforth (DB RCT) 47% 0.53 [0.38-0.71] symp. case 57/275 112/281 CT​1 Improvement, RR [CI] Treatment Control Tau​2 = 0.00, I​2 = 0.0%, p < 0.0001 Prophylaxis 47% 0.53 [0.38-0.71] 57/275 112/281 47% lower risk All studies 47% 0.53 [0.38-0.71] 57/275 112/281 47% lower risk 1 pHOXWELL COVID-19 study c19early.org December 2024 Tau​2 = 0.00, I​2 = 0.0%, p < 0.0001 Effect extraction pre-specified(most serious outcome) 1 CT: study uses combined treatment Favors pHOXWELL Favors control 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Balmforth (DB RCT) 47% 0.53 [0.38-0.71] symp. case 57/275 112/281 CT​1 Improvement, RR [CI] Treatment Control Tau​2 = 0.00, I​2 = 0.0%, p < 0.0001 Prophylaxis 47% 0.53 [0.38-0.71] 57/275 112/281 47% lower risk All studies 47% 0.53 [0.38-0.71] 57/275 112/281 47% lower risk 1 pHOXWELL COVID-19 case result c19early.org December 2024 Tau​2 = 0.00, I​2 = 0.0%, p < 0.0001 1 CT: study uses combined treatment Favors pHOXWELL Favors control 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Balmforth (DB RCT) 47% 0.53 [0.38-0.71] symp. case 57/275 112/281 CT​1 Improvement, RR [CI] Treatment Control Tau​2 = 0.00, I​2 = 0.0%, p < 0.0001 Prophylaxis 47% 0.53 [0.38-0.71] 57/275 112/281 47% lower risk All studies 47% 0.53 [0.38-0.71] 57/275 112/281 47% lower risk 1 pHOXWELL COVID-19 Randomized Controlled Trial c19early.org December 2024 Tau​2 = 0.00, I​2 = 0.0%, p < 0.0001 Effect extraction pre-specified(most serious outcome) 1 CT: study uses combined treatment Favors pHOXWELL Favors control 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Balmforth (DB RCT) 47% 0.53 [0.38-0.71] symp. case 57/275 112/281 CT​1 Improvement, RR [CI] Treatment Control Tau​2 = 0.00, I​2 = 0.0%, p < 0.0001 Prophylaxis 47% 0.53 [0.38-0.71] 57/275 112/281 47% lower risk All studies 47% 0.53 [0.38-0.71] 57/275 112/281 47% lower risk 1 pHOXWELL COVID-19 peer reviewed studies c19early.org December 2024 Tau​2 = 0.00, I​2 = 0.0%, p < 0.0001 Effect extraction pre-specified(most serious outcome) 1 CT: study uses combined treatment Favors pHOXWELL Favors control 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Balmforth (DB RCT) 47% 0.53 [0.38-0.71] symp. case 57/275 112/281 CT​1 Improvement, RR [CI] Treatment Control Balmforth (DB RCT) 63% 0.37 [0.25-0.54] IgG+ 36/275 97/281 CT​1 PHOXWELL COVID-19 outcomes c19early.org December 2024 1 CT: study uses combined treatment Favors pHOXWELL Favors control
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit